Related Experiment Video
Updated: Oct 18, 2025

11:36
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
11.0K
Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes
Lucas Cruz1,2,3, Paula Soares1,2,3,4, Marcelo Correia1,2
1i3S-Instituto de Investigação e Inovação Em Saúde, Universidade Do Porto, 4200-135 Porto, Portugal.
Pharmaceuticals (Basel, Switzerland)
|September 28, 2021
Summary
Ubiquitin-specific proteases (USPs) are key deubiquitinating enzymes involved in cellular homeostasis and cancer. This review details their roles in cancer development and current therapies targeting USP inhibitors.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ubiquitination is a crucial post-translational modification (PTM) regulating protein function, localization, and turnover.
- Deubiquitinating enzymes (DUBs) reverse ubiquitination, impacting ubiquitin dynamics.
- Ubiquitin-specific proteases (USPs) are the largest DUB family, implicated in diverse cellular processes.
Purpose of the Study:
- To review the multifaceted cellular functions of USPs in cancer development and progression.
- To explore the involvement of USPs in critical pathways like cell cycle regulation and DNA damage repair.
- To summarize current therapeutic strategies targeting USP inhibition for cancer treatment.
Main Methods:
- Literature review focusing on ubiquitin-specific proteases (USPs) and their roles in carcinogenesis.
- Analysis of studies investigating USP involvement in cell cycle, DNA repair, chromatin remodeling, and signaling pathways.
- Compilation of information on existing and emerging therapies targeting USP inhibitors.
Main Results:
- USPs play significant roles in cell cycle control, DNA damage repair, and chromatin remodeling.
- Dysregulation of USP activity is linked to the development and progression of various cancers.
- Targeting USP activity presents a promising avenue for novel cancer therapies.
Conclusions:
- USPs are critical regulators of cellular processes and are frequently implicated in cancer.
- Inhibition of specific USPs holds therapeutic potential for treating diverse malignancies.
- Further research into USP functions and targeted inhibitors is warranted for advancing cancer treatment.
Related Concept Videos
The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
Regulated Protein Degradation
7.9K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.9K
The Intrinsic Apoptotic Pathway
7.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.1K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
The Proteasome Structure
1.1K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.1K
Receptor Downregulation in MVBs
2.3K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.3K

